Merck’s fourth-quarter results top estimates, fueled by key cancer drugs and vaccines

Read Time:6 Second

Merck on Thursday reported fourth-quarter earnings and sales that beat analyst expectations, powered by strong growth in cancer and vaccine products.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

This week’s aggressive Fed rate cut could provide some breathing space for distressed companies, notes one bankruptcy attorney.

Investors are mulling strategies beyond cash on expectations that interest rates will continue to fall after the Fed’s big rate...

The package-delivery giant said reduced demand for priority services and higher operating costs weighed on results.

Elliott Hill will replace John Donahoe as chief executive next month, following months of struggles for the athletic-wear giant.

It’s that time again: Investors will see option contracts tied to more than $5 trillion in tradeable stocks expire on...

Mortgage rates inched up even though the Federal Reserve cut interest rates. Experts explain why this is a short-lived phenomenon.